'Weight Loss Injection': Cravings Disappear – Temporarily

The advent of 'weight loss injections' like Semaglutide and Tirzepatide represents a significant paradigm shift in the medical community's approach to obesity, as reported by Die Presse. Austrian experts, including Bernhard Ludvik of the Austrian Obesity Society, emphasize that these medications are not merely tools for cosmetic weight loss but are crucial in treating obesity as a complex disease. The article frames these drugs as a medical breakthrough, highlighting their ability to restore a disturbed appetite-regulation system, which is central to the condition. The comparison to bariatric surgery underscores the potency of these new treatments. Furthermore, the reporting delves into nuanced observations, such as the potentially greater efficacy in women and the specific impact on cravings for sweets. However, the piece maintains a balanced perspective by acknowledging the ongoing research into 'super-responders,' individual variability, and common side effects like nausea and constipation. The reassurance that concerns about increased cancer risk have been largely dismissed is also noted, though vigilance regarding other potential long-term effects, like a rare eye condition, continues. This comprehensive reporting reflects a serious medical and public health discussion within Austria and Germany about managing obesity effectively.

“

The weight loss injection is a medical breakthrough.